Sign inJoin waitlistJoin the waitlist

Luke Maese

Professor · Univ of Utah Sch of Med

Credentials: · · ·

History

Univ of Utah Sch of Med
Present

Pediatric Hematology Oncology
University of Utah School of Medicine
2012–2013
Pediatrics
UPMC Children's Hospital of Pittsburgh
2009–2012
KANSAS CITY UNIV OF PHYS AND SURG
2005–2009
University of Kansas
2001–2005

Research

Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 153 citations
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)
Neuro-Oncology · 2022 · 112 citations
Inherited TP53 Variants and Risk of Prostate Cancer
European Urology · 2022 · 74 citations

Jennie Vagher
14 papers
Joshua Schiffman
14 papers
Wendy Kohlmann
13 papers
Kara Maxwell
7 papers
Elizabeth Raetz
6 papers
Judy Garber
6 papers
Junne Kamihara
6 papers
Katherine Janeway
6 papers
Suzanne MacFarland
6 papers
AeRang Kim
5 papers
Alanna Church
5 papers
AS
Amit Sabnis
5 papers

Clinical trials

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2020–2028
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Site PI · Recruiting · Phase 3
Children's Oncology Group
2019–2032
Project: Every Child for Younger Patients With Cancer
Site PI · Recruiting
Children's Oncology Group
2015–2030